Anne-Marie Chaftari, M.D.

Peer-Reviewed Articles

1. Dagher, H, Hachem, RY, Hakim, C, Husni, R, Hammoudeh, DS, Karroum, MB, Hamerschlak, N, Assir, FF, Nasr, J, Rosenblatt, J, Jiang, Y, Wehbe, S, Zeenny, RM, Truong, YL, Chaftari, AP, Ghanem, O, Ibrahim, AE, Bizri, AR, Raad, II. A Prospective Randomised Clinical Study Comparing Polygalacturonic and Caprylic Acid Ointment to Medical-Grade Honey in the Management of Chronic Wounds. International Wound Journal 23(1), 2026. e-Pub 2026. PMID: 41574641.
2. Wehbe, S, Zakhour, R, Hachem, RY, Jiang, Y, Dagher, H, Salman, R, Chaftari, AP, Raad, II. Pediatric vs. Adult Invasive Aspergillosis in Cancer and Hematopoietic Transplant Patients. Journal of Fungi 11(11), 2025. e-Pub 2025. PMID: 41295152.
3. Turner NA, Hamasaki T, Doernberg SB, Lodise TP, King HA, Ghazaryan V, Cosgrove SE, Jenkins TC, Liu C, Sharma S, Zaharoff S, Wahid L, Renard VJ, Cook P, Raad I, Hachem R, Chaftari AM, Sims M, DeMarco C, Miller LG, McCarthy MW, Morse CG, Lucasti C, Forrest GN, Cherabuddi K, Polk C, Fazili T, Rupp ME, Thompson GR 3rd, Kim K, Strnad L, Schnee AE, McKinnell JA, Ramesh M, Silveira FP, McCarty TP, Lee TC, McDonald EG, Paolino K, Wiegand K, Wall A, Riccobene T, Patel R, Rappo U, Evans S, Chambers HF, Fowler VG Jr, Holland TL. Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial. JAMA, 2025. e-Pub 2025. PMID: 40802264.
4. Haddad A, Wilson Dib R, Chaftari AM, Jiang Y, Moussa M, Dagher H, Philip A, Hachem R, Raad I. Risk factors for catheter-related bloodstream infections in a high-risk cancer patient population. Infect Control Hosp Epidemiol 46(7):1-4, 2025. e-Pub 2025. PMID: 40415573.
5. Wehbe S, Chaftari AM, Hachem R, Dagher H, Haddad A, Philip A, Jiang Y, Zakhour R, Bakht P, Shrestha J, Lamie P, Sherchan R, Makhoul J, Chaftari P, Raad II. Prognostic Value of Serum and Bronchoalveolar Lavage Fluid Galactomannan Levels in Invasive Aspergillosis: An 8-Year Experience at a Tertiary Cancer Center. J Fungi (Basel) 11(5), 2025. e-Pub 2025. PMID: 40422689.
6. Dagher, H, Chaftari, AP, Haddad, AJ, Jiang, Y, Shrestha, J, Sherchan, R, Lamie, PM, Makhoul, J, Chaftari, P, Hachem, RY, Raad, II. Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment. Journal of Fungi 11(2), 2025. e-Pub 2025. PMID: 39997454.
7. Hachem, RY, Dagher, H, Chaftari, AP, Jiang, Y, Haddad, AJ, Wehbe, S, Shrestha, J, Sherchan, R, Lamie, PM, Makhoul, J, Chaftari, P, Raad, II. Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by Aspergillus terreus After the Introduction of Anti-Mold Azole Agents. Journal of Fungi 11(2), 2025. e-Pub 2025. PMID: 39997413.
8. Dagher H, Chaftari AM, Hachem R, Jiang Y, Philip A, Mulanovich P, Haddad A, Lamie P, Wilson Dib R, John TM, Dailey Garnes NJM, Ali S, Chaftari P, Raad II. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel) 16(20), 2024. e-Pub 2024. PMID: 39456544.
9. Chaftari AM, Dagher H, Hachem R, Jiang Y, Lamie P, Wilson Dib R, John T, Haddad A, Philip A, Alii S, Mulanovich P, Yuan Y, Chaftari P, Raad I. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother 79(10):2543-2553, 2024. e-Pub 2024. PMID: 39092963.
10. Gerges B, Rosenblatt J, Truong YL, Jiang Y, Shelburne SA Sr, Chaftari AM, Hachem R, Raad I Sr. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC Antimicrob Resist 6(2):dlae060, 2024. e-Pub 2024. PMID: 38601790.
11. Haddad, AJ, Hachem, RY, Moussa, M, Jiang, Y, Dagher, H, Chaftari, P, Chaftari, AP, Raad, II. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473412.
12. Gerges, B, Rosenblatt, J, Shellburne, SA, Chaftari, AP, Hachem, RY, Raad, II. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-Antimicrobial Resistance 5(6), 2023. e-Pub 2023. PMID: 38089460.
13. Dagher, H, Chaftari, AP, Subbiah, IM, Malek, A, Jiang, Y, Lamie, PM, Granwehr, BP, John, TM, Yepez Guevara, E, Borjan, J, Reyes-Gibby, CC, Flores, M, Khawaja, F, Pande, M, Ali, N, Rojo, R, Karp, DD, Chaftari, P, Hachem, RY, Raad, II. Long COVID in cancer patients. eLife 12, 2023. e-Pub 2023. PMID: 36748905.
14. Raad, II, Hachem, RY, Masayuki, N, Datoguia, TS, Dagher, H, Jiang, Y, Subbiah, V, Siddiqui, B, Bayle, A, Somer, RA, Fernández-Cruz, A, Gorak, E, Bhinder, A, Mori, N, Hamerschlak, N, Shelanski, S, Dragivich, T, Kiat, YV, Fakhreddine, S, Hanna, PA, Chemaly, RF, Mulanovich, VE, Adachi, JA, Borjan, J, Khawaja, F, Granwehr, BP, John, TM, Yepez Guevara, E, Torres, HA, Ammakkanavar, NR, Yibirin, M, Reyes-Gibby, CC, Pande, M, Ali, N, Rojo, RD, Ali, S, Deeba, R, Chaftari, P, Matsuo, T, Ishikawa, K, Hasegawa, R, Aguado-Noya, R, García, ÁG, Puchol, CT, Lee, DG, Slavin, MA, Teh, B, Arias, CA, Kontoyiannis, DP, Chaftari, AP. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer. eLife 12, 2023. e-Pub 2023. PMID: 36715684.
15. Dagher, H, Chaftari, AP, Mulanovich, P, Jiang, Y, Hachem, RY, Malek, A, Borjan, J, Viola, GM, Raad, II. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. eLife 11, 2022. e-Pub 2022. PMID: 36541589.
16. Chaftari, AP, Hachem, RY, Malek, A, Mulanovich, VE, Szvalb, AD, Jiang, Y, Yuan, Y, Ali, S, Deeba, R, Chaftari, P, Raad, II. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infectious Diseases 9(6), 2022. e-Pub 2022. PMID: 35663286.
17. Dagher, H, Hachem, RY, Chaftari, AP, Jiang, Y, Ali, S, Deeba, R, Shah, S, Raad, II. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. Journal of Fungi 8(1), 2022. e-Pub 2022. PMID: 35050014.
18. Chaftari, P, Chaftari, AP, Hachem, RY, Yeung, SJ, Dagher, H, Jiang, Y, Malek, A, Dailey Garnes, NM, Mulanovich, VE, Raad, II. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia. Cancer medicine 10(23):8475-8482, 2021. e-Pub 2021. PMID: 34725958.
19. Awadh, H, Chaftari, AP, Khalil, M, Fares, J, Jiang, Y, Deeba, R, Ali, S, Hachem, RY, Raad, II. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infectious Diseases 21(1), 2021. e-Pub 2021. PMID: 34225651.
20. Malek, A, Khalil, M, Hachem, RY, Chaftari, AP, Fares, J, Jiang, Y, Kontoyiannis, DP, Fossella, FV, Chaftari, P, Mulanovich, VE, Viola, GM, Raad, II. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients with Advanced Lung Cancer. Clinical Infectious Diseases 73(9):E2697-E2704, 2021. e-Pub 2021. PMID: 32564081.
21. Hachem, RY, Parikh, UM, Reitzel, R, Rosenblatt, J, Kaul, A, Vargas-Cruz, N, Hill, LR, Moore, L, Meyer, JM, Chaftari, AP, Gagea Iurascu, M, Balaji, S, Raad, II. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair and Regeneration 29(5):830-842, 2021. e-Pub 2021. PMID: 33956391.
22. Chaftari, P, Qdaisat, AZ, Chaftari, AP, Maamari, J, Li, Z, Lupu, F, Raad, II, Hachem, RY, Calin, GA, Yeung, SJ. Prognostic value of procalcitonin, C-reactive protein, and lactate levels in emergency evaluation of cancer patients with suspected infection. Cancers 13(16), 2021. e-Pub 2021. PMID: 34439240.
23. Shelburne, S, Dib, RW, Endres, BT, Reitzel, R, Li, X, Kalia, A, Sahasrabhojane, P, Chaftari, AP, Hachem, RY, Vargas-Cruz, N, Jiang, Y, Garey, K, Fowler, VG, Holland, T, Gu, J, Miller, WR, Sakurai, A, Arias, CA, Aitken, SL, Greenberg, DE, Kim, J, Flores, AR, Raad, II. Whole-genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteraemia is caused by a limited number of closely related sequence types. Clinical Microbiology and Infection 26(5):646.e1-646.e8, 2020. e-Pub 2020. PMID: 31639470.
24. Dib, RW, Khalil, M, Fares, J, Hachem, RY, Jiang, Y, Dandachi, D, Chaftari, AP, Raad, II. Invasive pulmonary aspergillosis. Journal of Hospital Infection 104(3):358-364, 2020. e-Pub 2020. PMID: 31585141.
25. Fares, J, Khalil, M, Chaftari, AP, Hachem, RY, Jiang, Y, Kantarjian, HM, Raad, II. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia. Open Forum Infectious Diseases 6(10), 2019. e-Pub 2019. PMID: 31660336.
26. Abu-Sbeih, H, Herrera, LN, Tang, T, Altan, M, Chaftari, AP, Okhuysen, PC, Jenq, RR, Wang, Y. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis. Journal for immunotherapy of cancer 7(1), 2019. e-Pub 2019. PMID: 31488205.
27. Vargas-Cruz, N, Rosenblatt, J, Reitzel, R, Chaftari, AP, Hachem, RY, Raad, II. Pilot Ex Vivo and in Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs). BioMed research international 2019, 2019. e-Pub 2019. PMID: 31976318.
28. Hachem, RY, Batista, MV, Kanj, SS, Zein, SE, Haddad, S, Jiang, Y, Mori, N, Vanderson, R, Chaftari, AP, Raad, II. International multicenter experience in the treatment outcome of invasive aspergillosis in immunocompromised cancer patients. Mediterranean Journal of Hematology and Infectious Diseases 11(1), 2019. e-Pub 2019. PMID: 30671209.
29. Vargas-Cruz, N, Reitzel, R, Rosenblatt, J, Chaftari, AP, Dib, RW, Hachem, RY, Kontoyiannis, DP, Raad, II. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for in Vitro Eradication of Candida auris Biofilm. Antimicrobial agents and chemotherapy 63(7), 2019. e-Pub 2019. PMID: 31036689.
30. Dib, RW, Hachem, RY, Chaftari, AP, Ghaly, F, Jiang, Y, Raad, II. Treating invasive aspergillosis in patients with hematologic malignancy. BMC Infectious Diseases 18(1), 2018. e-Pub 2018. PMID: 30545320.
31. Haddad, HE, Chaftari, AP, Hachem, RY, Micheal, M, Jiang, Y, Yousif, A, Raad, S, Jordan, M, Chaftari, P, Raad, II. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Scientific reports 8(1), 2018. e-Pub 2018. PMID: 29348438.
32. Dandachi, D, Dib, RW, Fernández-Cruz, A, Jiang, Y, Chaftari, AP, Hachem, RY, Raad, II. Invasive pulmonary aspergillosis in patients with solid tumours. Annals of Medicine 50(8):713-720, 2018. e-Pub 2018. PMID: 30230385.
33. Dib, RW, Chaftari, AP, Hachem, RY, Yuan, Y, Dandachi, D, Raad, II. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis. Open Forum Infectious Diseases 5(10), 2018. e-Pub 2018. PMID: 30377625.
34. Holland, T, Raad, II, Boucher, HW, Anderson, DJ, Cosgrove, SE, Suzanne Aycock, P, Baddley, JW, Chaftari, AP, Chow, SC, Chu, VH, Carugati, M, Cook, PP, Ralph Corey, G, Crowley, AL, Daly, JS, Gu, J, Hachem, RY, Horton, J, Jenkins, TC, Levine, D, Miro, JM, Pericas, JM, Riska, P, Rubin, Z, Rupp, ME, Schrank, J, Sims, M, Wray, D, Zervos, MJ, Fowler, VG. Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial. JAMA - Journal of the American Medical Association 320(12):1249-1258, 2018. e-Pub 2018. PMID: 30264119.
35. El Haddad, H, Chaftari, AP, Hachem, RY, Chaftari, P, Raad, II. Biomarkers of Sepsis and Bloodstream Infections. Clinical Infectious Diseases 67(6):971-977, 2018. e-Pub 2018. PMID: 29668936.
36. Raad, S, Chaftari, AP, Hachem, RY, Shah, PK, Natividad, E, Cleeland, C, Rosenblatt, J. Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden. Expert Review of Medical Devices 15(8):591-596, 2018. e-Pub 2018. PMID: 30067125.
37. Hachem, RY, Kanj, SS, Hamerschlak, N, Saad, H, Assir, FF, Mori, N, Jiang, Y, Ghaly, F, Chaftari, AP, Raad, II. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections. Expert Review of Medical Devices 15(6):461-466, 2018. e-Pub 2018. PMID: 29927699.
38. Chaftari, AP, Hachem, RY, Jiang, Y, Shah, PK, Hussain, A, Alhamal, ZS, Yousif, A, Jordan, M, Michael, M, Raad, II. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infection Control and Hospital Epidemiology 39(6):727-729, 2018. e-Pub 2018. PMID: 29770754.
39. Chaftari, AP, Hachem, RY, Raad, S, Jiang, Y, Natividad, E, Chaftari, P, Raad, II. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infection Control and Hospital Epidemiology 39(2):222-225, 2018. e-Pub 2018. PMID: 29331162.
40. Dib, RW, Hachem, RY, Chaftari, AP, Raad, II. Appropriate duration of intravenous treatment of candidemia and timing of step down to oral therapy in non-neutropenic patients. Mediterranean Journal of Hematology and Infectious Diseases 10(1), 2018. e-Pub 2018. PMID: 29755705.
41. Rosenblatt, J, Reitzel, R, Vargas-Cruz, N, Chaftari, AP, Hachem, RY, Raad, II. Caprylic and polygalacturonic acid combinations for eradication of microbial organisms embedded in biofilm. Frontiers in Microbiology 8(OCT), 2017. e-Pub 2017. PMID: 29093703.
42. Zakhour, R, Hachem, RY, Alawami, HM, Jiang, Y, Michael, M, Chaftari, AP, Raad, II. Comparing catheter-related bloodstream infections in pediatric and adult cancer patients. Pediatric Blood and Cancer 64(10), 2017. e-Pub 2017. PMID: 28409898.
43. Hachem, RY, Assaf, A, Numan, Y, Shah, PK, Jiang, Y, Chaftari, AP, Raad, II. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. International Journal of Antimicrobial Agents 50(3):384-388, 2017. e-Pub 2017. PMID: 28694233.
44. Chaftari, AP, Hachem, RY, Szvalb, AD, Taremi, M, Granwehr, BP, Viola, GM, Sapna, A, Assaf, A, Numan, Y, Shah, PK, Gasitashvili, K, Natividad, E, Jiang, Y, Tidwell, R, Reitzel, R, Rosenblatt, J, Mouhayar, E, Raad, II. A novel nonantibiotic nitroglycerin-based catheter lock solution for prevention of intraluminal central venous catheter infections in cancer patients. Antimicrobial agents and chemotherapy 61(7), 2017. e-Pub 2017. PMID: 28416559.
45. Vargas-Cruz, N, Reitzel, R, Rosenblatt, J, Jamal, M, Szvalb, AD, Chaftari, AP, Hachem, RY, Raad, II. In vitro study of antimicrobial percutaneous nephrostomy catheters for prevention of renal infections. Antimicrobial agents and chemotherapy 61(6), 2017. e-Pub 2017. PMID: 28320713.
46. Hilal, G, Reitzel, R, Alhamal, ZS, Chaftari, AP, Wohoush, IA, Jiang, Y, Hachem, RY, Raad, II. Novel plasma telomerase detection method to improve cancer diagnostic assessment. PloS one 12(5), 2017. e-Pub 2017. PMID: 28467443.
47. Hachem, RY, Reitzel, R, Rolston, KV, Chaftari, AP, Raad, II. Antimicrobial activities of ceftazidime-avibactam and comparator agents against clinical bacteria isolated from patients with cancer. Antimicrobial agents and chemotherapy 61(4), 2017. e-Pub 2017. PMID: 28115350.
48. Chaftari, P, Chaftari, AP, Adachi, JA, Hachem, RY, Raad, S, Natividad, E, Oliver, N, Ellickalputhenpura, BE, Jiang, Y, Tarrand, JJ, Raad, II. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. American Journal of Infection Control 45(3):e34-e39, 2017. e-Pub 2017. PMID: 28254252.
49. Rosenblatt, J, Reitzel, R, Vargas-Cruz, N, Chaftari, AP, Hachem, RY, Raad, II. Comparative efficacies of antimicrobial catheter lock solutions for fungal biofilm eradication in an in vitro model of catheter-related fungemia. Journal of Fungi 3(1), 2017. e-Pub 2017. PMID: 29371526.
50. Reitzel, R, Rosenblatt, J, Hirsch-Ginsberg, CF, Murray, KP, Chaftari, AP, Hachem, RY, Raad, II. In Vitro assessment of the antimicrobial efficacy of optimized nitroglycerin-citrate-ethanol as a nonantibiotic, antimicrobial catheter lock solution for prevention of central line-associated bloodstream infections. Antimicrobial agents and chemotherapy 60(9):5175-5181, 2016. e-Pub 2016. PMID: 27297475.
51. Yousif, A, Chaftari, AP, Michael, M, Jordan, M, Alhamal, ZS, Hussain, A, Elizabeth, N, Jiang, Y, Hachem, RY, Raad, II. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. American Journal of Infection Control 44(9):1037-1040, 2016. e-Pub 2016. PMID: 26897695.
52. Chaftari, AP, Jordan, M, Hachem, RY, Alhamal, ZS, Jiang, Y, Yousif, A, Garoge, K, Deshmukh, P, Raad, II. A clinical practical approach to the surveillance definition of central line–associated bloodstream infection in cancer patients with mucosal barrier injury. American Journal of Infection Control 44(8):931-934, 2016. e-Pub 2016. PMID: 27112370.
53. Raad, II, Chaftari, AP, Zakhour, R, Jordan, M, Alhamal, ZS, Jiang, Y, Yousif, A, Garoge, K, Mulanovich, VE, Viola, GM, Kanj, S, Pravinkumar, SE, Rosenblatt, J, Hachem, RY. Successful salvage of central venous catheters in patients with catheter-related or central line-associated bloodstream infections by using a catheter lock solution consisting of minocycline, EDTA, and 25% ethanol. Antimicrobial agents and chemotherapy 60(6):3426-3432, 2016. e-Pub 2016. PMID: 27001822.
54. Alhamal, ZS, Jordan, M, Hachem, RY, Alaami, HM, Alburki, AM, Yousif, A, Deshmukh, P, Jiang, Y, Chaftari, AP, Raad, II. Mycobacterium arupense in Cancer Patients. Medicine (United States) 95(14), 2016. e-Pub 2016. PMID: 27057825.
55. Chaftari, AP, Hachem, RY, Jordan, M, Garoge, K, Alhamal, ZS, El Zakhem, A, Viola, GM, Granwehr, BP, Mulanovich, VE, Gagel, A, Reitzel, R, Yousif, A, Jiang, Y, Raad, II. Case-control study of telavancin as an alternative treatment for gram-positive bloodstream infections in patients with cancer. Antimicrobial agents and chemotherapy 60(1):239-244, 2016. e-Pub 2016. PMID: 26482312.
56. Chaftari, AP, Hachem, RY, Reitzel, R, Jordan, M, Jiang, Y, Yousif, A, Garoge, K, Deshmukh, P, Alhamal, ZS, Jabbour, EJ, Hanania, A, Raad, S, Jamal, M, Raad, II. Role of procalcitonin and interleukin-6 in predicting cancer, and its progression independent of infection. PloS one 10(7), 2015. e-Pub 2015. PMID: 26148092.
57. Hachem, RY, Gomes, MZ, El Helou, G, El Zakhem, A, Kassis, C, Ramos, ER, Jiang, Y, Chaftari, AP, Raad, II. Invasive aspergillosis caused by Aspergillus terreus. Journal of Antimicrobial Chemotherapy 69(11):3148-3155, 2014. e-Pub 2014. PMID: 25006241.
58. Shelburne, S, Chaftari, AP, Jamal, M, Al Wohoush, I, Jiang, Y, Abughazaleh, S, Cairo, J, Raad, S, Debiane, LG, Raad, II. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer. American Journal of Infection Control 42(10):1127-1129, 2014. e-Pub 2014. PMID: 25278410.
59. Jamal, M, Rosenblatt, J, Jiang, Y, Hachem, RY, Chaftari, AP, Raad, II. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters. Antimicrobial agents and chemotherapy 58(9):5291-5296, 2014. e-Pub 2014. PMID: 24957841.
60. El Zakhem, A, Chaftari, AP, Bahu, RR, El Helou, G, Shelburne, S, Jiang, Y, Hachem, RY, Raad, II. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients. Annals of Medicine 46(3):163-168, 2014. e-Pub 2014. PMID: 24491173.
61. Jamal, M, Rosenblatt, J, Hachem, RY, Jiang, Y, Pravinkumar, SE, Nates, JL, Chaftari, AP, Raad, II. Prevention of biofilm colonization by gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrobial agents and chemotherapy 58(2):1179-1182, 2014. e-Pub 2014. PMID: 24165191.
62. Raad, II, Chaftari, AP. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clinical Infectious Diseases 59:S340-S343, 2014. e-Pub 2014. PMID: 25352628.
63. Debiane, LG, Hachem, RY, Wohoush, IA, Shomali, W, Bahu, RR, Jiang, Y, Chaftari, AP, Jabbour, EJ, Al Shuaibi, MM, Hanania, A, Pravinkumar, SE, Schuetz, P, Raad, II. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer. Critical care medicine 42(12):2500-2507, 2014. e-Pub 2014. PMID: 25083975.
64. Chaftari, AP, El Zakhem, A, Jamal, M, Jiang, Y, Hachem, RY, Raad, II. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infectious Diseases 14, 2014. e-Pub 2014. PMID: 25253042.
65. Raad, II, Chaftari, AP, Al Shuaibi, MM, Jiang, Y, Shomali, W, Cortes, JE, Lichtiger, B, Hachem, RY. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis. Annals of Oncology 24(7):1873-1879, 2013. e-Pub 2013. PMID: 23519997.
66. Shomali, W, Hachem, RY, Chaftari, AP, Bahu, RR, El Helou, G, Jiang, Y, Hanania, A, Reitzel, R, Raad, II. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?. Diagnostic Microbiology and Infectious Disease 76(2):158-161, 2013. e-Pub 2013. PMID: 23578976.
67. El Helou, G, Hachem, RY, Viola, GM, El Zakhem, A, Chaftari, AP, Jiang, Y, Tarrand, JJ, Raad, II. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clinical Infectious Diseases 56(6):843-846, 2013. e-Pub 2013. PMID: 23254418.
68. Bahu, RR, Chaftari, AP, Hachem, RY, Ahrar, K, Shomali, W, El Zakhem, A, Jiang, Y, Alshuaibi, M, Raad, II. Nephrostomy tube related pyelonephritis in patients with cancer. Journal of Urology 189(1):130-135, 2013. e-Pub 2013. PMID: 23164390.
69. Shomali, W, Hachem, RY, Chaftari, AP, Jiang, Y, Bahu, RR, Jabbour, EJ, Raad, S, Al Shuaibi, MM, Al Wohoush, I, Raad, II. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?. Cancer 118(23):5823-5829, 2012. e-Pub 2012. PMID: 22605389.
70. Chaftari, AP, Hachem, RY, Ramos, ER, Kassis, C, Campo, M, Jiang, Y, Prince, RA, Wang, W, Raad, II. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation 94(3):302-308, 2012. e-Pub 2012. PMID: 22814329.
71. Al Akhrass, F, Al Wohoush, I, Chaftari, AP, Reitzel, R, Jiang, Y, Ghannoum, M, Tarrand, JJ, Hachem, RY, Raad, II. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PloS one 7(3), 2012. e-Pub 2012. PMID: 22427914.
72. Raad, II, Jamal, M, Reitzel, R, Jiang, Y, Raad, S, Al Shuaibi, MM, Chaftari, AP, Hachem, RY. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrobial agents and chemotherapy 56(2):935-941, 2012. e-Pub 2012. PMID: 22123686.
73. Al Akhrass, F, Hachem, RY, Jamal, M, Tarrand, JJ, Kontoyiannis, DP, Chandra, J, Ghannoum, M, Haydoura, S, Chaftari, AP, Raad, II. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerging Infectious Diseases 17(9):1651-1658, 2011. e-Pub 2011. PMID: 21888790.
74. Chaftari, AP, Kassis, C, El Issa, H, Al Wohoush, I, Jiang, Y, Rangaraj, G, Caillouet, B, Pravinkumar, SE, Hachem, RY, Raad, II. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer 117(11):2551-2558, 2011. e-Pub 2011. PMID: 24048803.
75. Raad, II, Jamal, M, Reitzel, R, Jiang, Y, Dvorak, T, Ghannoum, M, Hachem, RY, Chaftari, AP. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes. Biomaterials 32(11):2689-2694, 2011. e-Pub 2011. PMID: 21295343.
76. Ramos, ER, Reitzel, R, Jiang, Y, Hachem, RY, Chaftari, AP, Chemaly, RF, Hackett, B, Pravinkumar, SE, Nates, JL, Tarrand, JJ, Raad, II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters. Critical care medicine 39(2):245-251, 2011. e-Pub 2011. PMID: 21057308.
77. Chaftari, AP, Hachem, RY, Mulanovich, VE, Chemaly, RF, Adachi, JA, Jacobson, K, Jiang, Y, Raad, II. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. International Journal of Antimicrobial Agents 36(2):182-186, 2010. e-Pub 2010. PMID: 20452752.
78. Ghide, S, Jiang, Y, Hachem, RY, Chaftari, AP, Raad, II. Catheter-related Corynebacterium bacteremia. European Journal of Clinical Microbiology and Infectious Diseases 29(2):153-156, 2010. e-Pub 2010. PMID: 20016995.
79. Raad, II, Kassar, R, Ghannam, D, Chaftari, AP, Hachem, RY, Jiang, Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia. Clinical Infectious Diseases 49(8):1187-1194, 2009. e-Pub 2009. PMID: 19780661.
80. Kassar, R, Hachem, RY, Jiang, Y, Chaftari, AP, Raad, II. Management of bacillus bacteremia. Medicine 88(5):279-283, 2009. e-Pub 2009. PMID: 19745686.

Review Articles

1. Viola, GM, Szvalb, AD, Malek, A, Chaftari, AP, Hachem, RY, Raad, II. Prevention of device-related infections in patients with cancer. CA Cancer Journal for Clinicians 73(2):147-163, 2023. e-Pub 2023. PMID: 36149820.
2. Reitzel, R, Rosenblatt, J, Chaftari, AP, Raad, II. Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition 43(7):832-851, 2019. e-Pub 2019. PMID: 31172542.
3. Chaftari, AP, Viola, GM, Rosenblatt, J, Hachem, RY, Raad, II. Advances in the prevention and management of central-line-associated bloodstream infections. Infection Control and Hospital Epidemiology 40(9):1036-1045, 2019. e-Pub 2019. PMID: 31230604.
4. Raad, II, Chaftari, AP, Dib, RW, Graviss, EA, Hachem, RY. Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East. Infection Control and Hospital Epidemiology 39(10):1230-1236, 2018. e-Pub 2018. PMID: 30099975.
5. Raad, II, Chaftari, AP, Torres, HA, Ayoub, EM, Narouz, LI, Bartek, J, Hachem, RY. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World Journal of Hepatology 10(9):549-557, 2018. e-Pub 2018. PMID: 30310533.
6. Zakhour, R, Chaftari, AP, Raad, II. Catheter-related infections in patients with haematological malignancies. The Lancet Infectious Diseases 16(11):e241-e250, 2016. e-Pub 2016. PMID: 27788992.
7. Al Shuaibi, MM, Bahu, RR, Chaftari, AP, Al Wohoush, I, Shomali, W, Jiang, Y, Debiane, LG, Raad, S, Jabbour, EJ, Al Akhrass, F, Hachem, RY, Raad, II. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clinical Infectious Diseases 56(7):943-950, 2013. e-Pub 2013. PMID: 23288950.

Other Articles

1. Abu-Sbeih, H, Herrera, LN, Tang, T, Altan, M, Chaftari, AP, Okhuysen, PC, Jenq, RR, Wang, Y Correction to. Journal for immunotherapy of cancer 7(1), 2019. PMID: 31847892.
2. Shomali, W, Hachem, RY, Chaftari, AP, Bahu, RR, El Helou, G, Jiang, Y, Hanania, A, Reitzel, R, Raad, II Corrigendum to “Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?” [Diagn Microbiol Infect Dis 2019;76(2):158–161] (Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia? (2013) 76(2) (158–161), (S0732889313001375), (10.1016/j.diagmicrobio.2013.03.004)). Diagnostic Microbiology and Infectious Disease 94(1):105, 2019. PMID: 30852051.
3. El Haddad, H, Chaftari, AP, Hachem, RY, Michael, M, Jiang, Y, Yousif, A, Raad, S, Jordan, M, Chaftari, P, Raad, II Erratum. Scientific reports 8(1):6258, 2018. PMID: 29674672.
4. Chaftari, AP, Hachem, RY, Szvalb, AD, Taremi, M, Granwehr, BP, Viola, GM, Amin, S, Assaf, A, Numan, Y, Shah, PK, Gasitashvili, K, Natividad, E, Jiang, Y, Tidwell, R, Reitzel, R, Rosenblatt, J, Mouhayar, E, Raad, II Correction for Chaftari et al., "A novel nonantibiotic nitroglycerin-based catheter lock solution for prevention of intraluminal central venous catheter infections in cancer patients" (Antimicrob Agents Chemother (2017) 61:7 (e00091-e00117) DOI: 10.1128/AAC.00091-17). Antimicrobial agents and chemotherapy 61(8), 2017. PMID: 28743701.
5. Al Shuaibi, MM, Bahu, RR, Chaftari, AP, Al Wohoush, I, Shomali, W, Jiant, Y Erratum. Clinical Infectious Diseases 57(5):779, 2013.

Abstracts

1. Malek AE, Chaftari P, Okhuysen PC, Dagher H, Torres HA, Hachem R, Chaftari AM, Viola GM, Kontoyiannis DP, Mulanovich VE, Raad II. Isoniazid therapy for latent tuberculosis infection in patients with cancer treated with checkpoint inhibitors immunotherapy. Open Forum Infectious Diseases - IDWEEK 2021 Virtual. e-Pub 2021.
2. Malek AE, Dagher H, Hachem R, Jiang Y, Chaftari AM, Raad I. A Comparison of Chest CT Findings in Cancer and non-Cancer Patients with COVID-19. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
3. Brock P, Wechsler A, Chaftari AM, Dagher H, Jiang Y, Lipe D, Chaftari P, Gaeta S, Johnson T, Coussirat D, Malek AE, Hachem R, Raad I. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
4. Dagher H, Malek AE, Chaftari AM, Subbiah IM, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Hachem R, Raad I. Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
5. Dagher H, Chaftari AM, Hachem R, Mulanovich P, Jiang Y, Malek AE, Garnes ND, Borjan J, Mulanovich V, Raad I. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients admitted with COVID-19. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
6. Chaftari AM, Malek AE, Dagher H, Jiang Y, Bayle A, Bhinder A, Fernandez Cruz A, Bilal Siddiqui B, Somer R, Datoguia T, Slavin M, Dragvich T, Gorak E, Mori N, Hachem R, Raad I. Lung cancer and hematologic malignancy ( HM) patients are associated with the highest risk of progressing to severe disease and mortality in cancer patients with COVID-19. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
7. b G, Rosenblatt J, Hachem R, Chaftari AM, Raad I. In Vitro Activity of Tebipenem Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer. Open Forum Infectious Diseases - IDWEEK 2021 Virtual, 2021. e-Pub 2021.
8. Chaftari A, Hachem R, Malek AE, Mulanovich V, Szvalb A, Jiang Y, Ali S, Deeba R, Chaftari P, Raad I. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies. ID Week 2020, Virtual Conference, Online, Oct 21, 2020, 2020. e-Pub 2020.
9. Malek AE, Chaftari P, Dagher HR, Hachem R, Chaftari AM, Viola GM, Raad II. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation. ID Week 2020, Virtual Conference, Online, Oct 21, 2020, 2020. e-Pub 2020.
10. Dagher H, Hachem R, Chaftari A, Jiang Y, Ali S, Deeba R, Shah S, Raad I. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. ID Week 2020, Virtual Conference, Online, Oct 21, 2020, 2020. e-Pub 2020.
11. Hachem R, Datoguia T, Siddiqui B, Cruz AF, Mori N. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study. ID Week 2020, Virtual Conference, Online, Oct 21, 2020, 2020. e-Pub 2020.
12. Chaftari P, MD, Chaftari A, MD, Hachem R, MD, Yeung SJ, MD, Dagher H, Jiang Y, MS, Malek A, MD, Mulanovich VE, MD, Raad I, MD. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center. ID Week 2020, Virtual Conference, Online, Oct 21, 2020, 2020. e-Pub 2020.
13. Dib RW, FernándezCruz A. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes. ID Week, October, 2018, San Francisco, California, 2018. e-Pub 2018.
14. Chaftari A, Dib RW, Kontoyiannis DP, Raad I. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution is highly effective in eradicating Candida auris biofilms. ID Week, October, 2018, San Francisco, California, 2018. e-Pub 2018.
15. Dib RW, Li X, Shelburne S, et al AC. Whole Genome Sequencing Analysis of a Large Cohort of Staphylococcus epidermidis Blood Culture Positive Isolates from a Multicenter Clinical Trial. ID Week, October, 2018, San Francisco, California, 2018. e-Pub 2018.
16. Reitzel R, Rosenblatt J, Hachem RY, et al AC. Repeated exposures to Minocycline/Rifampin and + Chlorhexidine combination used to coat catheters fails to induce antimicrobial resistance. ID Week, October, 2018, San Francisco, California, 2018. e-Pub 2018.
17. Dib RW, Chaftari A, Hachem RY, Jiang Y, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy. ID Week, October, 2018, San Francisco, California, 2018. e-Pub 2018.
18. Rosenblatt J, Reitzel R, Vargas-Cruz N, Hachem R, Chaftari AM, Wilson Dib R, Kontoyiannis D, Raad I. Candida auris Biofilm Eradication by Nitroglycerin-Citrate-Ethanol Catheter Lock Solution. Division of Internal Medicine Research Retreat, MDACC, May 2018, 2018. e-Pub 2018.
19. Reitzel R, Chaftari AM, Wilson Dib R, Fieldman A, Numan L, Hachem R, Rosenblatt J, Raad I. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas MD Anderson Cancer Center: a 26,000 parenteral nutrition-day experience. Division of Internal Medicine Research Retreat, MDACC, May 2018, 2018. e-Pub 2018.
20. Wilson Dib R, Chaftari AM, Hachem R, Dandachi D, Raad I. Catheter Related Staphylococcus Aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy. Division of Internal Medicine Research Retreat, MDACC, May 2018, 2018. e-Pub 2018.
21. Rosenblatt J, Reitzel R, Chaftari AM, Hachem R, Raad I. Antimicrobial Efficacy of Optimized Nitroglycerin+Citrate+Ethanol (NiCE) compared to Taruolidine+Citrate+Heparin (TCH) Catheter Lock Solutions against an extended panel of highly resistant Pathogens. GAP Conference 2017, Houston TX, 2017. e-Pub 2017.
22. Wilson Dib R, Chaftari AM, Ghaly F, Jiang Y, Hachem R, Raad I. Comparing Diagnostic Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
23. Raad S, Chaftari AM, Hachem R, Shah P, Natividad E, Cleeland CS, Rosenblatt J. Removal and Insertion of Central Venous Catheters for Bloodstream Infections Is Associated with High Symptom Burden. GAP Conference 2017, Houston TX, 2017. e-Pub 2017.
24. Chaftari AM, Raad S, Hachem R, Shah P, Jiang Y, Natividad E, Cleeland CS, Rosenblatt J, Raad I. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections: Impact on Symptom Burden. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
25. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Environmental disinfectant solutions achieves rapid kill against a broad spectrum of common resistant pathogens responsible for hospital associated infections. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
26. Hachem R, Reitzel R, Chaftari AM, Rolston KV, Raad I. In vitro activity of Ceftazidime-Avibactam (CAZ-AVI) and Comparator Agents against Resistant Clinical Bacteria Isolates from cancer patients. GAP Conference 2017, Houston TX, 2017. e-Pub 2017.
27. Hachem R, Kanj SS, Hamerschlak N, Saad H, Assir FF, Mori N, Jiang Y, Ghaly F, Chaftari AM, Raad I. Catheter Lock with Minocycline, EDTA and Ethanol for Salvaging of Central Venous Catheters in the Setting of Catheter Related Bloodstream Infections. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
28. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Antimicrobial Foley Catheter Flush/External Surface Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – An in vitro model. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
29. Chaftari AM, Hachem R, Shah P, Hussain HM, Al Hamal Z, Yousif A. Changing Epidemiology of Central Line Associated Blood Stream Infections (CLABSI) in Cancer Patients. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
30. Vargas-Cruz N, Reitzel R, Rosenblatt J, Jamal M, Szvalb A, Chaftari AM, Hachem R, Raad I. Activity of Antimicrobial Percutaneous Nephrostomy Catheters for the prevention of Renal Infections: In vitro studies. GAP Conference 2017, Houston TX, 2017. e-Pub 2017.
31. Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Sapna A, Assaf A, Yazan N, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Non-Antibiotic Nitroglycerin Based Catheter Lock Solution for the Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
32. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Comparative efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in vitro model of Catheter-Related Fungemia. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
33. Reitzel R, Rosenblatt J, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Novel, low-toxicity, disinfectant solution for rapid kill of common resistant pathogens responsible for hospital associated infections. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
34. Rosenblatt J, Reitzel R, Hachem R, Chaftari AM, Raad I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. GAP Conference 2017, Houston TX, 2017. e-Pub 2017.
35. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Foley Catheter with Peri-Urethral Antimicrobial Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – Assessment in an in vitro model. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
36. Rosenblatt J, Reitzel R, Vargas-Cruz N, Chaftari AM, Hachem R, Raad I. Comparative efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in vitro model of Catheter-Related Fungemia. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
37. Chaftari AM, Raad S, Hachem R, Shah P, Natividad E, Cleeland CS, Rosenblatt J, Raad I. Rates of Unnecessary Removal and Insertion of Central Venous Catheters in Cancer Patients with for Bloodstream Infections: Impact on Symptom Burden. 2017 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, Houston TX, 2017. e-Pub 2017.
38. Reitzel R, Chaftari AM, Feldman A, Numan LS, Hachem R, Rosenblatt J, Raad I. Catheter related complications and potential risk factors among catheterized cancer patients receiving parenteral nutrition at The University of Texas MD Anderson Cancer Center: a 26,000 parenteral nutrition-day experience. ID Week 2017, San Diego CA, 2017. e-Pub 2017.
39. Raad I, Chaftari AM, Zakhour R, Yousif A, Jiang Y, Jordan M, Al Hamal Z, Viola GM, Fisch M, Hachem R. Successful Salvage of vascular access in Central Line Associated Bloodstream Infections (CLABSI) Using Catheter Lock Consisting of Minocycline, EDTA and 25% Ethanol (M-EDTA-ETOH). ID Week 2015, San Diego CA, 2015. e-Pub 2015.
40. Zakhour R, Alawami H, Hachem R, Jiang Y, Michael M, Chaftari AM, Raad I. Current Epidemiology, Management and Outcome of Catheter-related Bloodstream Infections in a pediatric population: How is it different from adult population?. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
41. Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Antimicrobial Efficacy of Chlorhexidine-Minocycline/Rifampin (CHX-M/R) Coated Nephrostomy Catheter against Multi-drug Resistant Pathogens including Carbapenem-Resistant Enterobacteriaceae. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
42. Jamal M, Rosenblatt J, Chaftari AM, Jiang Y, Hachem R, Raad I. Development and Efficacy of Chlorhexidine (CHX)-Minocycline/Rifampin (MR) Impregnated Penile Implants Against Resistance Pathogenes. ID Week 2015, San Diego, CA, 2015. e-Pub 2015.
43. Chaftari AM, Alshuaibi M, Reitzel R, Jamal MA, Mary Jordan M, Jiang Y, Yousif A, Garoge K, Deshmukh P, Al Hamal Z, Jabbour J, Alex Hanania A, Sammy Raad S, Ray Hachem R, Raad I. Procalcitonin and Interleukin-6: Biomarkers of Cancer and Infection. ID Week 2014, Philadelphia, PA, 2014. e-Pub 2014.
44. Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, MD, Viola G, Granwwehr B, Gagel A, Ying Jiang Y, Shuaibi M, Issam Raad I. Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients. ID Week 2014, Philadelphia, PA, 2014. e-Pub 2014.
45. Hachem R, Chaftari AM, Yousif A, Al Hamal Z, Garoge K, Jordan M, Deshmukh P, Alshuaibi M, Rosenblatt J, Hamerschlak N, Sherif A, Kanj S, I Raad I. A Novel Lock Solution For Salvaging Central Venous Catheter (CVC) In The Setting Of A Central Line Associated Bloodstream Infection (CLABSI). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2014. e-Pub 2014.
46. Garoge K, Jamal MA, Rosenblatt J, Chaftari A, Hachem R, Raad II. Development Of Antimicrobial Coated Cannula For Continuous Subcutaneous Insulin Infusion (CSII) For Extended Durations. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2014. e-Pub 2014.
47. Jordan M, Al Hamal Z, Yousif A, Deshmukh P, Garoge K, Jiang Y, Hachem R, Chaftari AM, Raad I. How Often Is Central Line-Associated Blood Stream Infection (CLABSI) Identified As Catheter-Related Blood Stream Infection (CRBSI) In Cancer Patients? Challenging The New Guidelines. 54th Interscience Conference on Antimicrobial Agents and Chemotherap, Washington, DC, 2014. e-Pub 2014.
48. Rosenblatt, J, Reitzel, RA, Jamal, Hirsch-Ginsberg M, CF, Al Shuaibi M, Chaftari, AM, Hachem, R, Raad. Optimized Glyceryl Trinitrate (GTN)-Citrate-Ethanol Non-antibiotic, Antimicrobial Catheter Lock Solution for Prevention Of Central Line Associated Bloodstream Infections (CLABSIs). 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2014. e-Pub 2014.
49. Hachem R, Chaftari AM, El Zakhem A, Viola GM, Granwehr B, Gagel A, Alshuaibi M, Raad I. Efficacy and safety of telavancin in the treatment of Gram-positive bloodstream infections in cancer patients. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
50. Chaftari AM, Alshuaibi M, Jamal M, Reitzel R, El Zakhem A, Jiang Y, Hachm R, Raad, I. Role of Procalcitonin in Cancer Patients with Infections. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
51. El Zakhem A, Chaftar AM, Hachem R, Jiang Y, Raad I. Use of Antimicrobial Central Venous Catheters for Exchange Over Guidewire in Staphylococcus aureus Central Line Associated Bloodstream Infection. ID Week 2013, San Francisco, CA, 2013. e-Pub 2013.
52. Jamal M, Chaftari A, Dvorak T, Zakehm A, Rosenblatt J, Jiang Y. Prevention of Transmission of Multidrug-Resistant Organisms. 2013 ICCAC, Denver, CO, 2013. e-Pub 2013.
53. Jamal M, Rosenblatt J, Hachem R, Ying J, Chaftari AM, Raad I. Prevention of Gram-Negative Bacterial Biofilm on Catheters with Chlorhexidine-Minocycline/Rifampin by a Segregated Coating Method. 2013 Division of Internal Medicine Research Retreat, 2013. e-Pub 2013.
54. Chaftari AM, Alshuaibi M, Jamal M, Reitzel R, El Zakhem A, Jiang Y, Hachm R, Raad, I. Role of Procalcitonin in Cancer Patients with Infections. 2013 Division of Internal Medicine Research Retreat, MD Anderson Cancer Center, 2013. e-Pub 2013.
55. El Zakhem A, Chaftari AM, Ray, H, Jiang Y, Raad I. Use of Antimicrobial Central Venous Catheters for Exchange Over Guidewire in Staphylococcus aureus. 2013 Infections in Cancer Sympsoium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
56. Hachem R, Gilbert EH, Bahu R, Chaftari AM, Reitzel R, Dvorak T, Ying J, Tarrand J, Raad I. The Role of Procalcitonin and Pro-adrenomedullin in Differentiating the Causative Organisms in Bloodstream Infections. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
57. El Zakhem A, Chaftari AM, Hachem, Bahu R, El Helou G, AlShuaibi M Raad I. Staphylococcus Aureus (SA) Central Line Associated Bloodstream Infections (CLABSI) in Cancer Patients: Removal of the Catheter and Duration of Therapy, 2013. e-Pub 2013.
58. Mohamed J, Chaftari AM, Dvorak T, El Zakhem A, Rosenblatt J, Jiang Y, Hachem R, Raad I. Prevention of transmission of multi-drug resistant organisms during catheter exchange using antimicrobial catheters. 2013 Infections in Cancer Symposium, MD Anderson Cancer Center, Houston, TX, 2013. e-Pub 2013.
59. Mohamed JA, Hachem RY, Chaftari A, Jiang J, Raad I. Efficacy of a novel gendine coated peripherally inserted central venous catheters (PICC) against multidrug-resistant pathogens. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
60. Rosenblatt J, Hachem RY, Dvorak T, Reitzel R, Chaftari A, Alshuaibi M, Raad I. Glyceryl trinitrate (GTN) is useful as a novel non-antibiotic catheter lock for the prevention of intraluminal catheter biofilm colonization. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
61. Mohamed JA, Chaftari A, Hachem RY, Alshuaibi M, Raad I. Augmenting antibiotic-coated catheters (CVC) activity against bacterial biofilm adherence by impregnating the CVC with verapamil. 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
62. Shomali W, Hachem R, Chaftari AM, Bahu R, Jiang Y, Reitzel R, El Helou G, Raad I. The role of procalcitonin and pro-adrenomedullin in differentiating organisms causing staphylococcal bacteremia. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
63. Rosenblatt J, Hachem RY, Reitzel R, Chaftari A, Raad I. Pathogenesis and prevention of ventilator-associated pneumonia (VAP): an in vitro model using antimicrobial–coated endotracheal tube (ETT). 52th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2012. e-Pub 2012.
64. Hachem R, El Helou G, El Zakhem A, Shomali W, Jiang Y, Chaftari AM, Raad I. Caspofungin and voriconazole as primary and salvage therapy for patients with invasive aspergillosis in hematologic malignacy. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
65. Hachem R, El Helou G, El Zakhem A, Shomali W, Jiang Y, Chaftari AM, Raad I. Caspofungin and voriconazole as primary and salvage therapy for patients with invasive aspergillosis in hematologic malignacy. IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, 2012. e-Pub 2012.
66. Shomali W, Bahu R, Jiang Y, Hanania A, Raad S, Hachem R, A-M C, Raad I. Can procalcitonin (PCT) distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients (NNCP)?. 49th IDSA, 2011. e-Pub 2011.
67. Mohamed J, A-M C, Reitzel R, Jiang Y, Dvorak T, Hachem R, Raad I. Extended antimicrobial activity and prolonged durability of combination chlorhexidine (CHX) and minocycline/rifampin (M/A) coated vascular central vlenous catheters (CVC). 49th IDSA, 2011. e-Pub 2011.
68. Hachem R, Debian L, Shomali W, Bahu R, Al Wohoush I, Jian Y, Hanania A, Raad S, A-M C, Raad I. Comparing biomarkers procalcitonin (PCT) and Pro-adrenomedullin (PproADM) as a preditor of response to antibiotics in critically ill cancer patients with bacteremia and sepsis. 49th IDSA, 2011. e-Pub 2011.
69. El Helou G, Hachem R, A-M C, Jian Y, Tarrand J, Raad I. Rapidly growing mycobacteria (RGM) bacteremia in immun ocompromised patients, clinical experience of 74 patietns at MD Anderson Cancer Center. 49th IDSA, 2011. e-Pub 2011.
70. Hachem R, Mohamed J, Reitzel R, Jiang Y, Dvorak T, A-M C, Raad I. Comparison of three antimicrobial coated peripherally inserted central venous catheters (PICCs): What is on the horizon?. 49th IDSA, 2011. e-Pub 2011.
71. Bahu R, Shomali W, El Zakhem A, Ahrar K, A-M C, Jian Y, Hachem R, Raad I. Nephrostomy tube related infection (NTRI): Epidemiology, Risk Factors, and Infection Rate in Cancer Patients. 49th IDSA, 2011. e-Pub 2011.
72. Al Wohoush I, Hachem R, Debiane L, Jabbour J, Jiang Y, Al Akhrass F, Chaftari AM, Raad II. Procalcitonin is predictive of bloodstream infections nad metastatic disease but not localized bacterial infection in non-neutropenic cancer patients. 50th ICAAC, 2010. e-Pub 2010.
73. Raad II, Mohamed J, Reitzel R, Jiang Y, Chaftari A, Hachem R. Extended broad-spectrum activity of 2nd generation minocycline and rifampin-coated catheters against bacteria and fungi. 50th ICAAC, 2010. e-Pub 2010.
74. Raad II, Reitzel R, DvorakT, Jiang Y, Chaftari A, HachemR. Comparing chelator-based catheter lock solutions in eradicating organisms in biofilm on catheter surfaces. 50th ICAAC, 2010. e-Pub 2010.
75. Chaftari A, Hachem R, Kassis C, El Issa H, Kassar R, Jiang Y, raad I. Novel Antimicrobial Coated Catheters for the Salvage of the Vascular Access Site in Patients (pts) with Catheter-Related Bacteremia: A Retrospective Matched Controlled Study. 38th Critical Care Congress, 2009. e-Pub 2009.
76. Chaftari A, Hachem R, Kassis C, El Issa H, Kassar R, Jiang Y, Raad I. Novel Approach Using Antimicrobial Catheters for Catheter Exchange in Patients with Catheter-Related Bacteremia (CRB): A Matched Controlled Study. 49th ICAAC, 2009. e-Pub 2009.
77. Cairo J, Rangaraj G, A-M C, Granwehr B, Raad I. Is A Single Quantitative Blood Culture (QBC) Collected Through The Central Venous Catheter (CVC) Diagnostic of Catheter-Related Bloodstream Infections (CRBSIs)?. 47th IDSA, 2009. e-Pub 2009.
78. Hachem R, Mihu C, Kassis C, A-M C, Kontoyiannis DP, Raad I. Does the Combination of Lipid Formulation of Amphotericin B (L-AmB) and Echinocandins (ECH) Improve the Outcome of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP)?. 47th IDSA, 2009. e-Pub 2009.
79. Ramos ER, Jiang Y R, Tarrand J, Raad I, Hachem R, Reitzel R, Chaftari AM, Chem. The risk of emerging resistance associated with prolonged use of antibiotic-coated catheters: a seven year experience and >0.5 million catheter days. 46th IDSA, 2008. e-Pub 2008.
80. Chaftari AM, Hachem R, Mulanovich V, Chemaly R, Adachi J, Kassar R, Jiang Y, Raad I. Efficacy and Safety of Daptomycin in the Treatment of Gram Positive Catheter-Related Bloodstream Infections (CRBSI) in Cancer Patients. 48th ICAAC/46th IDSA Annual Meeting, 2008. e-Pub 2008.
81. Rosenblatt J, Reitzel R, Hachem R, Chaftari AM, Raad I. Efficacy of a Novel Synergistic Polygalacturonic + Caprylic Acid + Nitroglycerin Antimicrobial Wound Ointment Against Common Wound Pathogens in a Time-to-Kill Biofilm Eradication Model. ID Week 2017, San Diego CA.
82. Turner NA MD MHSc, Hamasaki T PhD, Evans S PhD, Doernberg SB MD MAS, Lodise TP PharmD PhD, King H PhD, Ghazaryan V MD MPH, Cosgrove SE MD, Jenkins TC MD MSc, Liu C MD, Sharma S MSc, Zaharoff S PhD, Wahid L MD, Cook P MD, Raad I MD, Hachem R MD, Chaftari AM MD, Sims M MD PhD, DeMarco C MD, Miller LG MD MPH, McCarthy MW MD, Morse CG MD MPH, Lucasti C MD, Forrest G MBBS, Cherabuddi K MD, Polk C MD, Fazili T MD, Rupp ME MD, Thompson GR MD, Kim K MD, Strnad L MD, Schnee AE MD, McKinnell JA MD, Ramesh M MD, Silveira FP MD MS, McCarty TP MD, Lee TC MD MPH, McDonald EG MSc, Paolino K MD MTM&H, Wiegand K MEng, Wall A MS, Riccobene T PhD, Patel R PharmD, Rappo U MD, Chambers HF MD, Fowler VG Jr MD MHS, Holland TL MD MSc, Antimicrobial Resistance Leadership Group. Dalbavancin is non-inferior to standard of care therapy for complicated Staphylococcus aureus bacteremia (SAB). ECCMID 2024 (34th European Congress of Clinical Microbiology and Infectious Diseases(.
83. Wehbe S, Chaftari AM, Hachem R, Dagher H, Haddad A, Philip A, Jiang Y, Zakhour R, Bakht P, Shrestha J, Sherchan R, Lamie P, Makhoul J, Chaftari P, Raad I. Prognostic value of serum and bronchoalveolar lavage fluid galactomannan in invasive aspergillosis: An 8-year experience at a tertiary cancer center. ESCMID Global 2025.
84. Rathore V, Chaftari AM, Hachem R, Rupp M, Mermel L, Czuczman M, Lader A, Raad I. Multi-Center, Randomized Study To Evaluate The Efficacy And Safety of Mino-Lok for the management of CLABSI In Hemodialysis Patients. SHEA Spring 2025.
85. Chaftari A, Rathore V, Hachem R, Huynh TT, Cook PP, Cantres-Fonseca O, Ramesh M, Rupp ME, Mermel L, Czuczman MS, Lader A, Raad I. A Phase 3 International, Multi-Center, Randomized, Open-Label, Assessor-Blind Study to Evaluate the Efficacy and Safety of Minocycline/EDTA/Ethanol (Mino-Lok) Therapy (MLT) vs Site-Specific Antimicrobial Lock in Combination with Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection. IDWeek 2025.
86. Truong, Y, Rosenblatt J, Gerges BZ, Jiang Y, Chaftari AM, Hachem RY, Lamie P, Kraus D, Raad II. Impact of Chlorhexidine Elution Profiles on Antifungal Durability of Two Chlorhexidine-Coated Antimicrobial Central Venous Catheters (CVCs). IDWeek 2025.
87. Truong Y BS, Rosenblatt J PhD, Gerges B PhD, Jiang Y MS, Chaftari A MD, Hachem R MD, Lamie P DO, Kraus D MD, Raad II MD. Antibiotic Elution Patterns Correlate with Antibacterial Activity of Three Antibiotic Antimicrobial Central Venous Catheters (CVCs). IDWeek 2025.
88. Wehbe S, Hachem RY, Dagher H, Jiang Y, Chaftari AM, Raad II. Pediatric vs. Adult Invasive Aspergillosis in Cancer and Hematopoietic Stem Cell Transplant Patients: Insights from a Matched Cohort at a Tertiary Cancer Center. IDWeek 2025.

Book Chapters

1. Chaftari, AP, Raad, II. Intravascular catheter-related infections, 717-721, 2015.

Letters to the Editor

1. Malek, A, Dagher, H, Hachem, RY, Chaftari, AP, Raad, II. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors?. Journal of medical virology 93: 4083-4084, 2021.
2. Melissa, K, Chaftari, AP, Hiba, D, Joel, R, Jiang, Y, Ruth A, R, Hachem, RY, Cheryl, HG, Raad, II. Efficacy of a nitroglycerin-citrate-ethanol lock solution in maintaining central venous catheter patency and preventing thrombotic occlusions in cancer patients. Thrombosis Research 201: 60-62, 2021.